Checkpoint
PascalFrancis
Racine
Checkpoint
PascalFrancis
Exploration
Accueil
Racine
Racine

Serveur d'exploration sur les relations entre la France et l'Australie

Attention, ce site est en cours de développement !
Attention, site généré par des moyens informatiques à partir de corpus bruts.
Les informations ne sont donc pas validées.

Lipoprotéine LDL And NotJohn C. Larosa

List of bibliographic references

Number of relevant bibliographic references: 5.
Ident.Authors (with country if any)Title
000332 Gilles Lambert [France, Australie] ; Francine Petrides [Australie] ; Mathias Chatelais [France] ; Dirk J. Blom [Afrique du Sud] ; Benjamin Choque [Australie] ; Fatiha Tabet [Australie] ; Gida Wong [Australie] ; Kerry-Anne Rye [Australie] ; Amanda J. Hooper [Australie] ; John R. Burnett [Australie] ; Philip J. Barter [Australie] ; A. David Marais [Afrique du Sud]Elevated Plasma PCSK9 Level Is Equally Detrimental for Patients With Nonfamilial Hypercholesterolemia and Heterozygous Familial Hypercholesterolemia, Irrespective of Low-Density Lipoprotein Receptor Defects
002931 Dick C. Chan [Australie] ; Gilles Lambert [Australie, France] ; P. Hugh R. Barrett [Australie] ; Kerry-Anne Rye [Australie] ; Esther M. M. Ooi [Australie] ; Gerald F. Watts [Australie]Plasma Proprotein Convertase Subtilisin/ Kexin Type 9: A Marker of LDL Apolipoprotein B-100 Catabolism?
002986 Gilles Lambert [Australie, France] ; Francesca Charlton [Australie] ; Kerry-Anne Rye [Australie] ; Derek E. Piper [États-Unis]Molecular basis of PCSK9 function
002A97 Amal Zerrad-Saadi [France] ; Patrice Therond [France] ; Sandrine Chantepie [France] ; Martine Couturier [France] ; Kerry-Anne Rye [Australie] ; M. John Chapman [France] ; Anatol Kontush [France]HDL3-Mediated Inactivation of LDL-Associated Phospholipid Hydroperoxides Is Determined by the Redox Status of Apolipoprotein A-I and HDL Particle Surface Lipid Rigidity: Relevance to Inflammation and Atherogenesis
003176 Vivienne M. Homer [Nouvelle-Zélande] ; A. David Marais [Afrique du Sud] ; Francesca Charlton [Australie] ; Andrew D. Laurie [Nouvelle-Zélande] ; Nicola Hurndell [Nouvelle-Zélande] ; Russel Scott [Nouvelle-Zélande] ; Fabien Mangili [Australie] ; David R. Sullivan [Australie] ; Philip J. Barter [Australie] ; Kerry-Anne Rye [Australie] ; Peter M. George [Nouvelle-Zélande] ; Gilles Lambert [Australie, France]Identification and characterization of two non-secreted PCSK9 mutants associated with familial hypercholesterolemia in cohorts from New Zealand and South Africa
Wicri

This area was generated with Dilib version V0.6.33.
Data generation: Tue Dec 5 10:43:12 2017. Site generation: Tue Mar 5 14:07:20 2024